SCHEMBL5514940

SCHEMBL5514940

CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(NCS(C)(=O)=O)ccc12

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
KCNH2 Q12809 2/20 0.44
CACNA1C Q13936 1/20 0.42
BCHE P06276 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839927 0.86 CYP2C9 (0.46) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2840204 0.84 CYP2C9 (0.46) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL14323627 0.83 CYP2C9 (0.45) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2843902 0.83 CYP2C9 (0.47) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2842699 0.81 CYP2C9 (0.46) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL5514943 0.80 CYP3A4 (0.52) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2834892 0.80 CYP3A4 (0.43) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2841656 0.80 CYP2C9 (0.58) CYP2C9CYP3A4CYP2C19KCNH2
SCHEMBL2835755 0.79 CYP2C9 (0.42) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C
SCHEMBL2840738 0.79 CYP2C9 (0.42) CYP2C9CYP3A4CYP2C19KCNH2CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265152-B2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases VIROPHARMA INCORPORATED (US) 2007-09-04 US claimed
US-7265152-B2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases VIROPHARMA INCORPORATED (US) 2007-09-04 US disclosed